Almost two years after publishing a controversial draft guidance on clinical decision support (CDS) software, the US Food and Drug Administration is taking another stab at the issue with an updated draft guidance to the delight of industry stakeholders.
On 26 September, the agency released the Clinical Decision Support Software guidance – a revised version of a document...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?